Brewing Better Health: Landmark Study Uncovers the Biological Ties Between Coffee and Liver Resilience on August 19, 2026 Posted by
Regaining Mobility: The 10-Minute Wall Routine to Rebuild Knee Strength After 60 on August 19, 2026 Posted by
The Circadian Anchor: Navigating the Complex Relationship Between Sleep and Bipolar Disorder on August 19, 2026 Posted by
Executive Shuffle: Anita Zielinski Departs Baxter to Lead Accounting at Cardinal Health on August 19, 2026 Posted by
Pulse of Contention: Physicians Challenge Big 12’s Monster Energy Partnership Amid Pediatric Health Fears on August 19, 2026 Posted by
The Kratom Paradox: Navigating the Complexities of a Controversial Botanical on August 19, 2026 Posted by
Mimicking the Complexity of Life: How Texas A&M’s New "Vessel-Chips" Are Revolutionizing Vascular Medicine on August 19, 2026 Posted by
Brewing Better Health: Landmark Study Uncovers the Biological Ties Between Coffee and Liver Resilience on August 19, 2026 Posted by
Regaining Mobility: The 10-Minute Wall Routine to Rebuild Knee Strength After 60 on August 19, 2026 Posted by
The Circadian Anchor: Navigating the Complex Relationship Between Sleep and Bipolar Disorder on August 19, 2026 Posted by
Executive Shuffle: Anita Zielinski Departs Baxter to Lead Accounting at Cardinal Health on August 19, 2026 Posted by
Posted in Sleep Health New Horizons in Narcolepsy Treatment: Alkermes Reports Sustained Efficacy for Alixorexton in Long-Term Extension Study on August 10, 2026
Posted in Sleep Health New Horizons in Narcolepsy Treatment: Alkermes Reports Sustained Efficacy for Alixorexton in Long-Term Study on August 2, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: Alkermes’ Alixorexton Shows Sustained Efficacy in Long-Term Clinical Study on July 25, 2026
Posted in Medical Innovations The Orexin Frontier: How Alkermes Is Positioning Its "Alixorexton" to Disrupt the Sleep Medicine Landscape on June 27, 2026
Posted in Sleep Health Advancing Sleep Medicine: Alkermes Secures Key Orphan Drug Designations for Alixorexton in Narcolepsy and Idiopathic Hypersomnia on June 17, 2026
